2025-090 Problems Notes Costs
Admission date2025-05-02
Final date -
Days in captivity35
SpeciesBWHA - Broad-winged hawk
AgeAHY
SexUNK
StatusReh
Band
Fracture - humerus, right
Sx - ESF Pins
Sx - IM Pin

Cause of injury: Collision - Vehicle

sx 5/6 Rads due 6/11

Found in Auburn,AL
Lee county
Here is a summary of this patient's treatments and expenses:

Desc Qty Cost Subtotal
Examination175.0075.00
Daily rate3520.00700.00
Radiographs787.75614.25
Physical therapy234.2268.44
Surgery, major1500.00500.00
Complete blood count158.0058.00
Packed cell volume18.078.07
Blood chemistry145.3545.35
Cytology134.3234.32
Lab tests1Variable40.00
Total  2143.43

Costs are estimates based on fees charged at a local avian specialist.
Radiographs and images

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-06

2025-05-28

2025-05-28

2025-05-28
2025-06-05 18:53 AD

Food: 19g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO

2025-06-05 09:49 AD

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-06-05 07:48 AD

BAR, 0 pellet, normal mutes, no leftovers

2025-06-04 18:59 AD

------------- LASER THERAPY ----------------
Power (joules): 312
Time: 5:12
Location: Right humerus
Notes: Performed over the medial and lateral aspects of the wing with concentration over the patagium and pectoral muscle directly proximal to the wing as well.

Bandage change: Vetwrap, foam padding, and cast padding was removed. The entry site for the intramedullary pin had a feather wrapped around the bar. When the feather was removed, the pin tract was mildly erythematous with mild swelling and moisture present. The other pin tracts were clean with no swelling, erythema, or discharge. All pin tracts were cleaned with dilute betadine in saline applied with a cotton tipped applicator with special attention to the IM pin tract. A piece of cotton was cut to cover the pin tract, and the external fixator was rewrapped with cast padding, a foam pad, and vetwrap.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before90130
After120160
Notes
Performed under anesthesia. The joints were stretched and held in extension for 10-15 seconds at a time. Greater extension was able to be performed under anesthesia, and the joints, while stiff, glided smoothly.
2025-06-04 16:20 AD

Food: 38g, Ch
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-06-04 09:18 AMS

======= TREATMENT PLAN =======
NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SID SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) BID PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
d/c ceftiofur

2025-06-04 08:20 AD
Weight: 337 grams
NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, 1 pellet, normal mutes, no leftovers
Weight: Weight loss 8% (-31g)

2025-06-03 16:35 AD

Food: 19g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-06-03 07:57 AD

Food: 22g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, no pellet, normal mutes, no leftovers

2025-06-02 16:52 PM

40g M
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment

2025-06-02 14:57 AD

------------- LASER THERAPY ----------------
Power (joules): 312
Time: 5:12
Location: Medial humerus, propagatium
Notes: The medial aspect of the humerus was treated as well as the propagatium and propagatial tendon. The pectoralis muscles immediately proximal to the wing were covered as well.

Physical therapy
Limb/jointRight wing
TypePROM
 ElbowWrist
Before  
After  
Notes
Awake passive range of motion physical therapy performed on the elbow and glenoid joints. Decreased range of motion of both joints, more markedly decreased at the elbow.
2025-06-02 08:28 SAK

======= TREATMENT PLAN =======
NPO
Ceftiofur Excede Q 96 hr: 0.07 ml (100 mg/ml) IM on 2025-06-05, 2025-06-09, 2025-06-13
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SID SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) BID PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================

2025-06-02 07:46 AD

NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, 0 pellets, normal mutes, no leftovers

2025-06-01 15:19 AD

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO

2025-06-01 09:24 AD

Food: 19g M, Ch
Ceftiofur Excede Q 96 hr: 0.07 ml (100 mg/ml) IM
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, 1 pellet, normal mutes, no L/O

2025-05-31 14:56 DBT

Food: 23g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO

2025-05-31 10:08 DBT

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-05-30 17:46 re

Food:40g m
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO

2025-05-30 16:00 AD

Physical therapy: Passive range of motion performed on elbow and shoulder joints. Arm and shoulder felt stiff during PT and has decreased range of motion of right wing.

2025-05-30 09:20 DBT

NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

BAR 1 pellet, Normal Mutes, NOLO

2025-05-29 16:09 DBT

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO

2025-05-29 11:24 re

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

BAR, no pellet, normal mutes, no leftovers

2025-05-28 17:53 re

======= TREATMENT PLAN =======
NPO
Ceftiofur Excede Q 96 hr: 0.07 ml (100 mg/ml) IM on 2025-06-01, 2025-06-05, 2025-06-09,
2025-06-13
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SID SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) BID PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
==============================

2025-05-28 17:40 MR

80g m
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) PO
Ceftiofur Excede Q 96 hr: 0.07 ml (100 mg/ml) IM

2025-05-28 16:00 AD

Clinical Pathology Report:

Description: The smears have similar findings. There is abundant blood and a small amount of extracellular lipid. Leukocytes are present in type and number consistent with blood. Rare microfilaria are observed on two of the smears. The microfilaria are ~200 microns in length and 15-25 microns wide with a tapered tail and granular internal structure. There are no overt bacteria observed.

Opinion: Poorly cellular sample; blood and rare microfilaria.

Comments: The aspirates from the described mass contain only blood, with no tissue cells for interpretation. These findings could indicate that mass is a hematoma or an area of hemorrhage associated with the healing fracture. Additionally, there could be a poorly exfoliative mass. There are no overt bacterial organisms observed. Please use the results from the bacterial culture performed to guide potential treatment. The microfilaria observed may originate from subcutaneous tissues or blood and are generally considered non-pathogenic. Please correlate with clinical findings.

Cytology report
Collection date2025-05-28
LocationProximal right humerus at most proximal ESF pin
StainGram

Findings
Findings could indicate the mass is a hematoma or an area of hemorrhage associated with the healing fracture. Additionally, there could be a poorly exfoliative mass. There are no overt bacterial organisms observed. (Whole resport in main text box).
Diagnosis
2025-05-28 14:34 re

Imagery report
Date2025-05-28
TypeRadiograph
Performed by
Positioningextended R caudocranial, extende
EquipmentRadiograph machine
Location
Anesthesia
ISO via mask
Comments
In extended right caudocranial and extended right lateral view there are concerns regarding loss of cortex and lytic region surrounding the exit site of the most proximal external fixator pin. The appearance of the cortex appears to be more than a suspected halo artifact surrounding the pin, and there is concern of bacterial infiltration to the site. An ultrasound guided fine needle aspirate was taken from the site and submitted for cytology, anaerobic, and aerobic culture and susceptibility. 
2025-05-28 14:04 SAK

======= TREATMENT PLAN =======
NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SID SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.11 ml (100mg/ml soln) BID PO
Meloxicam: 0.12 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
==============================

2025-05-28 13:34 SAK

Updated medication doses based on a latest weight of 368 g

2025-05-28 09:41 re
Weight: 368 grams
NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

Weight gain 4% (+14g)

BAR, 1 pellet, normal mutes, no leftovers

2025-05-28 08:25 SAK

======= TREATMENT PLAN =======
NPO
Buprenorphine SR: 0.06 ml (1.8 mg/ml SR) SID SQ (PT Days only)
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
==============================

2025-05-27 17:43 re

Food: 21g m
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO

2025-05-27 13:30 re

Food: 20g m
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

BAR, normal mutes, no leftovers, one pellet

2025-05-27 13:25 re

BAR, normal mutes, no leftovers, one pellet

2025-05-26 15:24 Payton McCaleb

Food: 21g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO

2025-05-26 08:59 Payton McCaleb

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, no pellet, 4g LO

2025-05-25 15:28 Payton McCaleb

Food: 23g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-05-25 09:12 Payton McCaleb

Food: 21g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, no pellet, no LO

2025-05-24 15:32 Payton McCaleb

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO

2025-05-24 09:10 Payton McCaleb

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR, no pellet, no LO

2025-05-23 15:33 JMH

Food: 40g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO BID

2025-05-23 08:31 JMH

NPO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO BID
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO SID (0.5mg/kg dosing)
Radiograph: Right Wing
Laser therapy:
PT: PROM Wing

BAR
No Pellet
0g LO

2025-05-22 17:05 JMH

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln)BID PO

2025-05-22 09:50 JMH

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO SID
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

BAR
1 Pellet
0g LO

2025-05-21 15:42 JMH

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)

2025-05-21 09:06 JMH
Weight: 354 grams
Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
BAR
No pellet
No LO

PT: yesterday afternoon still showed some limited ROM in right elbow
Wt gain (+16%) in last week (0.5 mg/kg meloxicam dose updated with new weight)

2025-05-20 16:54 JMH

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO BID

2025-05-20 10:34 JMH

NPO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) PO (0.5mg/kg dosing)
PT: PROM Wing
BAR
1 pellet
No left overs

2025-05-20 09:20 AMS

======= TREATMENT PLAN =======
NPO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.1 ml (1.5 mg/ml soln) SID PO (0.5mg/kg SID dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
changed meloxicam to 0.5mg/kg SID dosing

2025-05-19 17:10 AN

Food: 18g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)

2025-05-19 10:20 JMH

======= TREATMENT PLAN =======
Food: 20g M, Ch BID
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) SID PO (SID dosing)
==============================

2025-05-19 10:09 AN

Food: 18g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)

2025-05-18 15:22 BT

Food: 22g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO

2025-05-18 09:18 BT

Food: 19g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)
BAR, 1 pellet, NOLO, Normal Mutes

2025-05-17 15:21 BT

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO

2025-05-17 09:21 BT

Food: 20g M, Ch
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)
BAR, 1 pellet, NOLO

2025-05-16 16:09 JMH

Food:44g M, Ch BID
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln)BID PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)
Laser therapy: right wing 312j
PT: PROM right Wing
Wound care/bandage change: cta w/ betadine solution and Triple Antibiotic Ointment

2025-05-16 10:52 Payton McCaleb

NPO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) PO (SID dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
BAR, no pellet, no L/O

2025-05-16 10:04 AMS

======= TREATMENT PLAN =======
NPO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.20 ml (1.5 mg/ml soln) SID PO (SID dosing)
Laser therapy:
PT: PROM Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
d/c TMS, decrease melox to SID

2025-05-15 16:24 JMH

Food: 19g M, Ch
TMS: 0.29 ml (48 mg/ml)BID PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln)BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln)BID PO

2025-05-15 11:03 BT

offered mealworms

2025-05-15 10:02 BT

Food: 20g M, Ch
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

BAR, no pellets, no LO, Normal mutes

2025-05-15 08:58 SAK

======= TREATMENT PLAN =======
Food: 20g M, Ch BID
TMS: 0.29 ml (48 mg/ml) BID PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
============================== Update PT/Rads/Bchange/Laser dates

2025-05-14 16:39 JMH

Food: 20g M, Ch (GIVE MEDS ORALLY) Watch food intake carefully
TMS: 0.29 ml (48 mg/ml)BID PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln)BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO

2025-05-14 10:15 re
Weight: 304 grams
Food: 21g M, Ch (GIVE MEDS ORALLY) Watch food intake carefully
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO
BAR, 1 pellet, no leftovers, normal mutes

Weight loss 5% (-17g)

2025-05-14 08:12 re

======= TREATMENT PLAN =======
Food: 20g M, Ch (GIVE MEDS ORALLY) BID Watch food intake carefully
TMS: 0.29 ml (48 mg/ml) BID PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
==============================
d/c bupe

2025-05-13 17:16 Payton McCaleb

Food: 40g M, Ch
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-13 12:02 SAK

NPO
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO
BAR, normal mutes, no pellet, no leftovers

2025-05-13 11:20 re
Weight: 321 grams
Weight gain 16% (+45g)

2025-05-13 09:38 SAK

======= TREATMENT PLAN =======
NPO
TMS: 0.29 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ on 2025-05-16
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
Radiograph: Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
Bup on PT days only

2025-05-13 09:03 SAK

======= TREATMENT PLAN =======
NPO
TMS: 0.29 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
Radiograph: Wing
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
Switch off AF.

2025-05-12 16:04 Payton McCaleb

Assisted feed: 20g M, Ch cut up
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-12 10:53 SAK

Assisted feed: 22g M, Ch cut up
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

Pellet, normal mutes

2025-05-11 15:29 LIA

Assisted feed: 21g M cut up
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-11 09:34 LIA

Assisted feed: 20g M cut up
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

BAR, bandaged intact, normal mutes, 0 pellets

2025-05-10 16:09 BC

Assisted feed: 21g M cut up
TMS: 0.29 ml (48 mg/ml) PO
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-10 10:20 BC

Assisted feed: 20g M cut up
SQ fluids: 14ml LRS SW (maint)
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

Bandage remained intact

2025-05-10 08:45 Taylor Hopkins

BAR, normal mutes, no pellet, no leftovers (assist fed), bandage intact

2025-05-09 17:05 BC

Patient was anesthetized and its bandage was removed. Surgical site was assessed as well as the fracture site on the ventral aspect of the wing. External fixator still appears to be stable. Tissue appears to be healing appropriately with expected bruising and swelling present. Laser therapy was performed. Incision site and pin sites were cleaned with betadine and mupirocin ointment was placed around pins and incision. Range of motion was determined to be excellent in carpus and elbow. Bandage was replaced by placing telfa pads over the incision and around pins and then wrapping external fixator with cast padding and placing a Styrofoam padding over the cast padding. It was then wrapped with vet-wrap. No wing to body bandage was placed in order to give patient time to attempt to move affected wing.

------------- LASER THERAPY ----------------
Power (joules): 312
Time: 5 min 12 sec
Location: From shoulder joint to elbow joint.
Notes: Time was split between dorsal and ventral aspect of the wing.

2025-05-09 16:15 LIA

Assisted feed: 20g M,AM +PM food combined
SQ fluids: missed
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO
Wound care/bandage change: . Use Triple Antibiotic Ointment

2025-05-09 10:19 SAK

======= TREATMENT PLAN =======
Assisted feed: 20g M, Ch cut up BID
SQ fluids: 14ml LRS SW (maint) SID until 2025-05-10
TMS: 0.29 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Gabapentin Oral Susp 30 mg per kg: 0.08 ml (100mg/ml soln) BID PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
Add gaba

2025-05-09 07:21 LIA

NPO bandage change
BAR, normal mutes, no pellet, bandage intact, 25g leftovers

2025-05-08 16:41 BT

Assisted feed: 20g M, Ch cut up

TMS: 0.29 ml (48 mg/ml) PO
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-08 11:45 BT

Food: 20g M, Ch cut up
SQ fluids: 14ml LRS SW (maint) until 2025-05-10
TMS: 0.29 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.18 ml (1.5 mg/ml soln) PO

2025-05-08 08:27 SAK

======= TREATMENT PLAN =======
Assisted feed: 20g M, Ch cut up BID
SQ fluids: 14ml LRS SW (maint) SID until 2025-05-10
TMS: 0.29 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================
Add sq LRS maint

2025-05-08 08:25 SAK

======= TREATMENT PLAN =======
Assisted feed: 20g M, Ch cut up BID
TMS: 0.29 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.18 ml (1.5 mg/ml soln) BID PO
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================

2025-05-08 07:58 BC

Patient was BAR
Patient had 17 g left over.
Patient had normal urate and feces but no pellet.

2025-05-07 17:00 BC

Food: 21g M fed. 1 piece assist fed and left the other 3 pieces in the enclosure.
TMS: 0.33 ml (48 mg/ml) PO
Meloxicam: 0.22 ml (1.5 mg/ml soln) PO
Wound care/bandage change: Patient was anesthetized and bandage was removed. Wound had minimal serosanguinous discharge. Patient also had moderate bruising and swelling that was to be expected. Range of motion was assessed. Range of motion of carpus and elbow was excellent. Laser therapy was performed. Pins were cleaned with betadine CTAs. Triple antibiotic ointment is applied at the pin sites and along incision site. Telfa padding was placed over incision and around pins and cast padding, Styrofoam pad, and vet wrap was placed around external fixator. Wing to body bandage was replaced.


------------- LASER THERAPY ----------------
Power (joules): 312
Time: 5 min 12 sec
Location: From shoulder to elbow
Notes: Time was split between dorsal and ventral aspect of wing. Laser therapy was performed around surgical area and wounds from fracture.

2025-05-07 16:43 re

Electrophoresis Comments
The albumin is decreased as is the overall total protein. This may reflect hydration, nephritis, hepatitis,
or parasitism. By %TP, the beta globulins are increased and reflective of acute inflammation.
Moderate to marked increases in this fraction can be observed with nephritis, hepatitis, dermatitis,
and mycotic infection. Increases may also be observed with sarcocystosis and chronic chlamydiosis
as well as mycobacteriosis. Specific beta globulin proteins which often manifest as a monoclonal
appearing peak in this fraction are also increased in egg laying birds. Followup EPH may have
prognostic value in this case.

Serum chemistry
Collection date2025-05-07
AST744 U/LPhos3.3 mg/dl
BA1 umol/LTP3.0 g/dl
CK9938 U/LAlb0.0 g/dl
UA14.6 mg/dlGlob0.0 g/dl
Glu358 mg/dlK+0.0 mmol/l
Ca10.0 mg/dlNa+0 mmol/l
  AMY683 U/L
Hem , Lip , Ict
CBC
Collection date2025-05-07
WBC count23100
Corrected count23100
Hets/Neut69% - 15939
  Bands0+
  Toxics0+
Lymphs25% - 5775
Eos1% - 231
Mono3% - 693
Baso2% - 462
Thrombocytesadequate
PI2
HemoproteusNEG
LeukocytozoonNEG
PlasmodiumNEG
Read byUMiami Avian & Wildlife Lab
W BC Morphology: Reactive lymphocytes [Rare ]
2025-05-07 16:05 BT

Updated medication doses based on a latest weight of 276 g

2025-05-07 13:33 SAK
Weight: 276 grams
Drew 1ml blood from right jugular for intake labwork.

Weight loss 14% BW

PCV/TP
Collection date2025-05-07 13:33:00
PCV38 %
TS3.2 g\dl
Serum
Blood lead
Collection date2025-05-07
Level0.00
2025-05-07 12:20 BT

Assist feed: 20g M, Ch
TMS: 0.33 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.22 ml (1.5 mg/ml soln) PO

2025-05-07 09:13 BC
Weight: 276 grams
Patient was weighed- 276 g (14% decrease)

2025-05-07 08:33 SAK

======= TREATMENT PLAN =======
Food: 20g M, Ch BID
TMS: 0.33 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.22 ml (1.5 mg/ml soln) BID PO
Wound care/bandage change: . Use Triple Antibiotic Ointment
==============================

2025-05-06 18:27 BC

Surgery report
Procedure - Fracture repair - humerus
Performed by - Sokoloff
Surgery time - 98 minutes

Pre-surgical radiographs were performed. These radiographs confirmed
a diaphyseal humeral fracture, but also revealed numerous comminuted
portions of the fracture. It was decided that we would proceed
with surgery. Patient was placed in ventral recumbency and the
wing was prepped from shoulder to the elbow joint. An incision
was made above the fracture site. An IM pin was placed in a retrograde
fashion. The IM pin was inserted first into the proximal fragment,
exiting at the pectoral crest. The fracture was then reduced
and the pin was then driven into the distal fragment. The incision
was sutured closed with 5-0 PDS. 2 ESF pins were placed, one
in the proximal portion of the proximal fragment and one in the
distal portion of the distal fragment. An external fixator was
then connected to the ESF pins and the IM pin. The incision site
was cleaned with betadine and triple antibiotic ointment was
placed on the site of each pin. Telfa pads were placed around
each pin location and the fixator was wrapped with cast padding
and vet wrap. The right wing was then placed in a wing to body
wrap with silk tape. 
2025-05-06 16:03 Taylor Hopkins

Food: 23g M offered
TMS 0.33ml (48mg/ml) BID PO
Meloxicam 0.22ml (1.5mg/ml) BID PO (1mg/kg)
Wing Wrap Bandage intact

2025-05-06 11:18 AMS

Food: Assist fed clean/organ meat from 1 mouse, did not leave any in cage due to sx later today
TMS: 0.33 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.22 ml (1.5 mg/ml soln) PO
Wing wrap in place

42g leftovers (all from previous day)

AMS

2025-05-05 17:42 BC

Fed 31 g M
TMS: 0.33 ml (48 mg/ml) PO
Meloxicam: 0.22 ml (1.5 mg/ml soln) PO
Wound care/bandage change: Patient was placed under anesthesia and wing to body bandage was removed. Feathers were plucked at site of right humeral fracture and revealed small open wounds on the dorsum and ventrum of the wing. Wounds were cleaned with betadine and mupirocin ointment was placed around wounds. Telfa pads with tegaderm were placed over wounds on both ventral and dorsal aspect. Wing to body bandage was replaced with silk tape in order to stabilize the fracture. Anesthesia was started at 4:53 PM and ended at 5:14 PM
Check wing wrap, replace if needed

2025-05-05 13:00 SAK

NPO
34g LO from 5/4/25
Pellet/urates/feces present

2025-05-05 08:39 SAK

======= TREATMENT PLAN =======
NPO
TMS: 0.33 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.22 ml (1.5 mg/ml soln) BID PO
Wound care/bandage change:
Check wing wrap BID, replace if needed
==============================

2025-05-04 16:46 Taylor Hopkins

Food: 16g M TMS: 0.33 ml (48 mg/ml) PO- put in food
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) SQ
Check wing wrap, replace if needed- Patient was BAR and its wing to body wrap was still intact.

2025-05-04 09:52 Taylor Hopkins

Food: 20g M
TMS: 0.33 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) SQ
Patient was BAR and had normal urates and feces. No pellets were noted. Patient had no left overs in enclosure. Wing to body bandage is still intact but had to be re-taped due to patient getting their foot stuck in the vet wrap.

2025-05-03 16:16 BC

Food: 16g M
SQ fluids: 8ml
TMS: 0.33 ml (48 mg/ml) PO
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) SQ
Check wing wrap, replace if needed

Patient was BAR and its wing to body wrap was still intact.

2025-05-03 11:13 BC

Food: 16g M
SQ fluids: 8ml until 2025-05-03
TMS: 0.33 ml (48 mg/ml) PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) SQ

Patient was BAR and had normal urates and feces. No pellets were noted. Patient had no left overs in enclosure. Wing to body bandage appeared to still be intact

2025-05-02 17:51 AMS

======= TREATMENT PLAN =======
Food: 16g M BID
SQ fluids: 8ml BID until 2025-05-03
TMS: 0.33 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.05 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.06 ml (5 mg/ml (Injectable)) BID SQ
Check wing wrap BID, replace if needed
==============================

2025-05-02 17:47 AMS
Weight: 322 grams

2025-05-02 17:22 BT

Food: 30 g. M

2025-05-02 16:38 SAK

Sample
Collection date2025-05-02
Typechoanal/cloacal swab
Notes:
Results:
AI PCR : not detected
2025-05-02 10:30 BC
Weight: 322 grams, BCS: 2.5

------------- PHYSICAL EXAM FINDINGS ----------------
Attending Veterinarian: Dr. Amberly Sokoloff
Observational examination
Mentation: Quiet, alert, and responsive
Posture: Patient has normal posture
Overall appearance: Right wing is drooping
Vital stats
Heart rate: 460 bpm
Respiratory rate: 80 brpm
Auscultation: No abnormalities auscultated
Mucous membranes: Pink
Hydration: 5-10%
Comments: Patient had a slow ulnar vein refill time.
Oral cavity: Oral cavity was clear
Choana: Choana was clear
Glottis: Glottis was open and clear.
Beak: Beak appeared normal.
Cere/nares: Nares were open with no obstructions present.
Eyes: No abnormalities present.
Ears: No abnormalities present.
Crop: No abnormalities present
Feather quality: Numerous secondary flight feathers were blood feathers.
Integument: Bleeding from dorsal aspect of right wing above proximal humerus where fracture is. A hippoboscid fly was also found on this patient.
Wings: Left wing appeared normal. Right wing was dangling when patient was picked up. Patient appeared unable to move the right wing at all.
Wings - Range of motion: Left wing's range of motion was normal. Right wing had limited to no range of motion.
Wings - Patagium: No abnormalities noted
Legs/Feet: No abnormalities noted
Legs/Feet - Range of motion: Patient had normal range of motion in its legs.
Legs/Feet - Plantar surface: No abnormalities noted
Legs/Feet- Talons: No abnormalities noted
Neurologic: Patient appeared to be neurologically stable
Ceolom: No abnormalities noted on palpation
BCS: 2
Vent: No abnormalities present
Droppings: Not examined
Uropygial gland: No abnormalities present
Problem list: 1. Open transverse proximal diaphyseal fracture on right humerus
2. Hippoboscid fly
Diagnosis: 1. Right humeral fracture on proximal diaphysis

Assessment: Overall, the patient's prognosis is gaurded. The patient appears unable to use the right wing and the fracture is close to the shoulder joint. Depending on how close this fracture is to the shoulder joint, fracture repair may not be possible.
Plan: Tx: Patient was treated with meloxicam and buprenorphine for pain and a wing to body wrap was placed in order to stabilize the fractured wing. TMS was also given to treat any potential infections that could be occurring. Subcutaneous fluids were also administered to promote proper hydration. Dx: Radiographs of the fracture were performed and determined that there could potentially be enough space between the fracture and the shoulder joint to attempt fracture repair.
Prognosis: Fair

2025-05-02 04:30 BC

Whole body radiographs were taken. A VD view was taken and revealed a proximal diaphyseal humeral compound fracture. The fracture appeared to have potential to be repaired via surgery. Plan to retake radiographs

Version 4.0.4 - 4.0.13 Fri Jun 6 03:00:32 2025